Natixis’s iShares Biotechnology ETF IBB Stock Holding History

Natixis’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500,000	Closed	-$67.7M	–	1069
2020 Q3	$67.7M	Buy	+500,000	New	+$67.8M	0.5%	50
2019 Q4	–	Sell	-1,251,208	Closed	-$125M	–	892
2019 Q3	$125M	Buy	1,251,208 +279	+0%	+$29.2K	0.8%	22
2019 Q2	$136M	Buy	1,250,929 +500,326	+67%	+$53.2M	1.05%	16
2019 Q1	$83.9M	Sell	750,603 -1,522	-0.2%	-$167K	0.53%	37
2018 Q4	$72.5M	Buy	752,125 +1,573	+0.2%	+$167K	0.6%	39
2018 Q3	$91.5M	Sell	750,552 -499,448	-40%	-$58.8M	0.53%	56
2018 Q2	$137M	Buy	1,250,000 +100,000	+9%	+$10.7M	0.73%	27
2018 Q1	$123M	Buy	1,150,000 +992,783	+631%	+$110M	0.75%	26
2017 Q4	$16.8M	Sell	157,217 -892,783	-85%	-$95.4M	0.13%	160
2017 Q3	$117M	Buy	1,050,000 +891,033	+561%	+$95.2M	1.08%	20
2017 Q2	$16.4M	Buy	+158,967	New	+$15.7M	0.19%	126
2017 Q1	–	Sell	-451,176	Closed	-$39.9M	–	979
2016 Q4	$39.9M	Buy	+451,176	New	+$41.1M	0.41%	59
2016 Q1	–	Sell	-5,709	Closed	-$644K	–	340
2015 Q4	$644K	Buy	+5,709	New	+$620K	0.01%	213

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Natixis's IBB Position: Q4 2020 in Review

Natixis sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 500,000 shares — an estimated $67.7M sold.

Natixis first reported a position in IBB in Q4 2015 and held it in 13 quarters. The position peaked at $137M in Q2 2018. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Natixis reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Natixis sold 500,000 iShares Biotechnology ETF shares in Q4 2020, an estimated $67.7M.
Natixis first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 13 quarters.
Natixis's iShares Biotechnology ETF position peaked at $137M in Q2 2018.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Natixis's 13F filing for Q4 2020, filed 12 Feb 2021.